Reblozyl

View On IPO.GOV.UK

Registered

on 9 Oct 2023

Last Applicant/ Owned by

Celgene Corporation

86 Morris Avenue, Summit, New Jersey 07901, United States of America

, ,

Serial Number

UK00003965162 filed on 9^th Oct 2023

Registration Number

UK00003965162 registered on
29^th Dec 2023

Correspondent Information

Sipara Limited

Rochester House, Eynsham Road, Farmoor

Oxford,

OX2 9NH

Reblozyl

pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.

Classification Information

Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.

UK00003965162

Figurative

Individual